A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

por Mihaljevic, Andre, Büchler, Peter, Harder, Jan, Hofheinz, Ralf, Gregor, Michael, Kanzler, Stephan, Schmiegel, Wolff, Heinemann, Volker, Endlicher, Esther, Klöppel, Günter, Seufferlein, Thomas, Geissler, Michael
Publicado 2009

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of...

por Luber, Birgit, Deplazes, Joëlle, Keller, Gisela, Walch, Axel, Rauser, Sandra, Eichmann, Martin, Langer, Rupert, Höfler, Heinz, Hegewisch-Becker, Susanna, Folprecht, Gunnar, Wöll, Ewald, Decker, Thomas, Endlicher, Esther, Lorenzen, Sylvie, Fend, Falko, Peschel, Christian, Lordick, Florian
Publicado 2011